Microtransplantation for advanced or relapsed solid tumors
Part of Cancer clinical trials.
This trial tests a new treatment called microtransplantation for people with advanced or relapsed solid tumors. It aims to see if it is safe and effective, and may offer a new option when other treatments have not worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 90 years old.
- You must have an advanced or relapsed solid tumor (such as lung, ovarian, cervical, stomach, colorectal, sarcoma, or head and neck cancer).
- You must have at least one tumor that can be measured on a scan.
- You must be able to take care of yourself at least partially (score of 40 or higher on the Karnofsky scale, or 0 to 3 on the ECOG scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JMKX005425 for people with advanced solid tumors that have a specific genetic feature called MSI-H or dMMR. If you have this feature and your cancer has not responded to other treatments, this study may offer a new option.
This trial tests a new drug, SCTB39G, for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it can shrink tumors and improve survival, and to find the best dose. Participation involves regular treatment and check-ups.
This trial tests an experimental drug called KM602 for people with advanced solid tumors that have stopped responding to standard treatments, particularly melanoma and non-small cell lung cancer. It aims to see if the drug is safe and effective in shrinking or controlling tumors.
This trial tests a new experimental medicine called SGT003 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the medicine is safe, how the body handles it, and whether it can shrink tumors or slow their growth.
This study tests a new drug called MST-168 for people with advanced solid tumors (cancers that have spread or can't be removed). It aims to find out if the drug is safe and effective, and how the body handles it, which could lead to a new treatment option for those who have run out of standard options.
This trial tests a new drug called AMT-676 in people with advanced solid tumors that have not responded to standard treatments. It may be an option for those with certain cancers like colorectal, stomach, or pancreatic cancer.
Hear when a new Advanced and Relapsed Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.